A meta-analysis conducted by Xu et al. confirms the susceptibility of PNPLA3 rs738409 polymorphism to NAFLD and the risk of developing NASH [162], and the results are consistent with a previous meta-analysis [163]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.